IRCT20181026041466N6招募中1 期
Clinical study of safety and efficacy of DMA110 topical gel in the treatment of genital wart from Papillomavirus.
Rayka raya teb co0 个研究点目标入组 80 人开始时间: 待定最近更新:
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 发起方
- 入组人数
- 80
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- no limit 至 no limit（—）
- 性别
- All
入选标准
- •All patients with genital warts
排除标准
- •Patients who need to take immune suppressive drugs such as corticosteroids , chemotheraputic drugs or undergoing radiation therapy.
- •Patients suffering from immune deficiency-associated diseases such as diabetes, cancer, HIV.
- •A wound or active skin disease other than wart at the treatment site
研究者
相似试验
已完成
不适用
The clinical study of the safety and efficacy of docetaxel combined with ribavirin in docetaxel resistant castration resistant prostate cancerProstate cancerJPRN-UMIN000015130Keio University School of Medicine, Department of Urology20
进行中（未招募）
1 期
Efficacy and Safety of AM-111 in the Treatment of Acute InnerEar Hearing LossEUCTR2013-002077-21-CZAuris Medical AG255
进行中（未招募）
1 期
Efficacy and Safety of AM-111 in the Treatment of Acute InnerEar Hearing LossEUCTR2013-002077-21-HUAuris Medical AG255
进行中（未招募）
1 期
Efficacy and Safety of AM-111 in the Treatment of Acute InnerEar Hearing LossIdiopathic sudden sensorineural hearing lossMedDRA version: 19.1Level: PTClassification code 10043882Term: TinnitusSystem Organ Class: 10013993 - Ear and labyrinth disordersEUCTR2013-002077-21-DEAuris Medical AG255
进行中（未招募）
1 期
Efficacy and Safety of AM-111 in the Treatment of Acute InnerEar Hearing LossIdiopathic sudden sensorineural hearing lossMedDRA version: 19.1Level: PTClassification code 10043882Term: TinnitusSystem Organ Class: 10013993 - Ear and labyrinth disordersEUCTR2013-002077-21-BGAuris Medical AG255